Black Diamond Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDTX and other ETFs, options, and stocks.About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases.
BDTX Key Statistics
Stock Snapshot
With a market cap of 103.96M, Black Diamond Therapeutics(BDTX) trades at $1.76. The stock has a price-to-earnings ratio of -2.32.
On 2026-07-25, Black Diamond Therapeutics(BDTX) stock traded between a low of $1.75 and a high of $1.83. Shares are currently priced at $1.76, which is +0.6% above the low and -3.8% below the high.
Black Diamond Therapeutics(BDTX) shares are trading with a volume of 611.15K, against a daily average of 670.85K.
During the past year, Black Diamond Therapeutics(BDTX) stock moved between $1.60 at its lowest and $4.94 at its peak.
During the past year, Black Diamond Therapeutics(BDTX) stock moved between $1.60 at its lowest and $4.94 at its peak.
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.